Cargando…
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
It has been 34 months since the beginning of the SARS-CoV-2 coronavirus pandemic, which causes the COVID-19 disease. In several countries, immunization has reached a proportion near what is required to reach herd immunity. Nevertheless, infections and re-infections have been observed even in vaccina...
Autores principales: | Pacheco-García, Ursino, Serafín-López, Jeanet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055900/ https://www.ncbi.nlm.nih.gov/pubmed/36992239 http://dx.doi.org/10.3390/vaccines11030655 |
Ejemplares similares
-
Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022) -
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022) -
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020) -
SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022) -
Vanadyl Sulfate Effects on Systemic Profiles of Metabolic Syndrome in Old Rats with Fructose-Induced Obesity
por: Ortega-Pacheco, Diego, et al.
Publicado: (2018)